You are here: Industry Insights > Series D Financing

News List

Atonarp Announces $50M Series D Financing to Scale its Molecular Sensing and Digital Diagnostics Testing Platforms prnasia
May 18, 2021
Atonarp, a leading manufacturer of molecular sensing and diagnostics products for the healthcare, pharma, and semiconductor industries, today announced it has raised a $50 million Series D financing, led by WRVI Capital.
Sirnaomics seals $105m Series D financing for RNAi therapeutics pharmaceutical-business-review
October 28, 2020
Sirnaomics Inc., a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced today that it has sealed its USD$105 million Series D financing.
Orca Bio raises $192m to support cell therapies development pharmaceutical-technology
June 19, 2020
US-based biotechnology firm Orca Bio has raised $192m in a Series D financing round to support the development of cell therapies intended to provide an alternative for standard bone marrow transplants.
Promethera Biosciences completes €39.7 M Series D Financing biospectrumasia
May 09, 2019
The round was co-led by new Japanese investors ITOCHU Corporation